US Declines Prosecuting Biomedical Company That Reported Bribery

US prosecutors declined to prosecute Lifecore Biomedical after the publicly-traded pharmaceutical manufacturer self-disclosed bribing the Mexican government.

The company’s timely reporting—within three months of first uncovering the wrongdoing—and its move to terminate and withhold pay from the officer who engaged in the scheme factored into the declination, the Justice Department said Friday.

DOJ described several details weighing in favor of lenience for Lifecore that shed light on newly revised policies aimed at incentivizing businesses to confess white-collar crimes by offering clearer paths to a declination.

Defense counsel discussing the possibility of taking advantage of DOJ’s policy shifts have sought ...